In GSK’s first quarter with Luke Miels as CEO, the company’s flagship shingles vaccine Shingrix set a new quarterly sales ...

GlaxoSmithKline (NYSE:GSK) dermatology and skin subsidiary Stiefel has submitted to regulators a new drug application for tazarotene foam, an acne skin care treatment product. If approved by the U.S.

Final data from the AZUR-1 trial is highly anticipated later this year after a collaborative study with MSK showed a 100 percent complete response rate for the PD-1 inhibitor.

GlaxoSmithKline‘s (NYSE:GSK) efforts to clear its figurative medicine cabinet of unwanted over-the-counter products continues as the pharma giant reaches a deal to sell a group of consumer brands to ...

GSK is a pharmaceutical company with key segments in specialty medicine, general medicine, and vaccines. Economic uncertainties arise from political forces, inflation rates and signs of a recession, ...

LEBANON, N.H., April 15, 2026 /PRNewswire/ -- Adimab, LLC, the global leader in the discovery and engineering of fully human monoclonal and multispecific antibodies, congratulates GSK plc for recently ...

GSK trades at lower price multiples compared to competitors due to weaker pipeline. GSK's revenue growth in 2023 was modest, but it has strong performers in its product mix. GSK needs to demonstrate ...

LONDON/MUMBAI (Reuters) - Indian generics firm Lupin , some U.S. drugmakers looking for a tax-saving deal in Europe and private equity funds are planning to bid for a range of older drugs being ...

Drugmaker GSK said on Monday that its relapsed/refractory multiple myeloma treatment Blenrep had received approval from China ...

The Philippine Food and Drug Administration (FDA) has issued draft regulations on the conduct of clinical trials. The document sets out general principles covering clinical trials run in the ...

US regulators have withdrawn their approval of a GSK Plc drug that the Trump administration had promoted as a treatment for ...

LONDON/MUMBAI (Reuters) - Generics firm Lupin , some U.S. drugmakers looking for a tax-saving deal in Europe and private equity funds are planning to bid for a range of older drugs being auctioned by ...